Pilatus Biosciences, Inc., a clinical-stage biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, today announced the first patient ...

Medical Facilities Corporation ("Medical Facilities," "MFC," or the "Corporation") , reported its financial results today for the fourth quarter and year ended December 31, 2025. All amounts are ...

Understanding Aging Through Simulation The Role of Simulation in Empathy Training It’s tough to really get what ...